Last updated: February 9, 2024
Sponsor: University of Southern Denmark
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Ulcerative Colitis
Colic
Ulcers
Treatment
High gluten diet
Gluten free diet
Clinical Study ID
NCT06249763
Gluten-UC
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis: Ulcerative Colitis (UC)
- Language: Can read and understand Danish
- Treatment: No intention to change dose of, begin, or switch medication and biologictreatment within one month after inclusion
- Treatment: Medical and/or biologic treatment type and dose stable for at least 8-16weeks prior to inclusion depending on the type of treatment
Exclusion
Exclusion Criteria:
- Age: <18 years
- Severe disease activity defined by 6 or more bloody stools per day and/or night andone of the following: fever, pulse ≥ 90, C-reactive protein (CRP) ≥ 30mg/L by the timeof inclusion
- Treatment: Have received antibiotic treatment within 4 weeks prior to inclusion
- Treatment: Previous operation for UC
- Concomitant diagnoses: Coeliac Disease (positive Immunoglobolin A againsttransglutaminase, TGA-IgA) or any cancer diagnosis
- Other: Taking probiotics, are pregnant or breastfeeding, or have nut or wheat allergy
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: High gluten diet
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
May 31, 2025
Study Description
Connect with a study center
Hospital of Southern Jutland
Aabenraa, 6200
DenmarkSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.